Development of Early Diagnostic Techniques and Setup of Local Therapeutic Guidelines and Standards
NCT ID: NCT00912704
Last Updated: 2009-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
1998-03-31
1998-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chronic Kidney Disease at Northeast Taiwan: Biomarker and Multidisciplinary Care
NCT04300387
Population-based Chronic Kidney Disease Cohort at Northern Taiwan
NCT03004898
Early Screening and Diagnosis of CKD
NCT02841371
Chronic Kidney Disease Prevention of An-Lo District, Keelung
NCT00644046
Circulating lncRNA and CV Morbidities in CKD and ESRD
NCT02304471
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Design: The group plans to host the co-operation of hospitals, based on the geographical distribution of co-operation of several hospitals to choose the renal physician interviews the doctor and patient received a total of 30 objects was conducted qualitative in-depth interviews.
Time:2008/9/1\~2011/8/31
Inclusion criteria): To withdraw from dialysis treatment of chronic kidney disease, qualitative research, to-depth interviews, field observation, video recording, and public hospitals at the same time the collection of literature.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wake Forest University Health Sciences
OTHER
Far Eastern Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chang Duan-Rong, doctor
Role: PRINCIPAL_INVESTIGATOR
the Institute of Health Care Organization Administration (IHCOA)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
098001-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.